Structures cataloged on encounter. Each entry is a permanent record of what the Voyager observed and what HOUSTON enriched.

TCR-based therapeutics targeting intracellular cancer antigens on solid tumors

AI-driven platform developing molecular glue therapeutics for undruggable targets in immunology

Epitope resolution platform discovering novel cancer targets for multiple therapeutic modalities

Develops molecular glue therapeutics for targeted protein degradation in cancer

Develops bispecific antibodies targeting complement system for cancer and autoimmune diseases

Develops DNASE1L3-based enzyme therapies targeting NETs in autoimmune disease

Developing switchable allogeneic CAR-T platform for hematological cancers and autoimmune diseases

Develops tRNA therapeutics to restore protein function in genetic diseases